323 related articles for article (PubMed ID: 23399369)
1. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
[TBL] [Abstract][Full Text] [Related]
2. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
3. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
4. Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program.
Tiblad E; Taune Wikman A; Ajne G; Blanck A; Jansson Y; Karlsson A; Nordlander E; Holländer BS; Westgren M
PLoS One; 2013; 8(8):e70984. PubMed ID: 23940682
[TBL] [Abstract][Full Text] [Related]
5. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
Slootweg YM; Koelewijn JM; van Kamp IL; van der Bom JG; Oepkes D; de Haas M
BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
Moncharmont P
Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
[TBL] [Abstract][Full Text] [Related]
7. The scientific basis of antenatal prophylaxis.
Urbaniak SJ
Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
[TBL] [Abstract][Full Text] [Related]
8. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
[TBL] [Abstract][Full Text] [Related]
9. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
10. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
[TBL] [Abstract][Full Text] [Related]
11. DEL RBC transfusion should be avoided in particular blood recipient in East Asia due to allosensitization and ineffectiveness.
Shao CP; Wang BY; Ye SH; Zhang WL; Xu H; Zhuang NB; Wu XY; Xu HG
J Zhejiang Univ Sci B; 2012 Nov; 13(11):913-8. PubMed ID: 23125084
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
[TBL] [Abstract][Full Text] [Related]
13. Serological weak D phenotypes: a review and guidance for interpreting the RhD blood type using the RHD genotype.
Sandler SG; Chen LN; Flegel WA
Br J Haematol; 2017 Oct; 179(1):10-19. PubMed ID: 28508413
[TBL] [Abstract][Full Text] [Related]
14. Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review.
Runkel B; Bein G; Sieben W; Sow D; Polus S; Fleer D
BMC Pregnancy Childbirth; 2020 Feb; 20(1):83. PubMed ID: 32033599
[TBL] [Abstract][Full Text] [Related]
15. Patients with Asian-type DEL can safely be transfused with RhD-positive blood.
Ji Y; Luo Y; Wen J; Sun Y; Jia S; Ou C; Yang W; Chen J; Ye H; Liu X; Liang Y; Lu Z; Feng Y; Wu X; Xiao M; Mo J; Zhou Z; Wang Z; Liao Z; Chen J; Wei L; Luo G; Santoso S; Fichou Y; Flegel WA; Shao C; Li C; Zhang R; Fu Y
Blood; 2023 Apr; 141(17):2141-2150. PubMed ID: 36638337
[TBL] [Abstract][Full Text] [Related]
16. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
Cortey A; Brossard Y
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
[TBL] [Abstract][Full Text] [Related]
18. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation.
Pilgrim H; Lloyd-Jones M; Rees A
Health Technol Assess; 2009 Feb; 13(10):iii, ix-xi, 1-103. PubMed ID: 19210896
[TBL] [Abstract][Full Text] [Related]
19. Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.
Kent J; Farrell AM; Soothill P
BMC Pregnancy Childbirth; 2014 Feb; 14():87. PubMed ID: 24568571
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.
Koelewijn JM; de Haas M; Vrijkotte TG; van der Schoot CE; Bonsel GJ
BJOG; 2009 Sep; 116(10):1307-14. PubMed ID: 19538414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
